An omics-based strategy using coenzyme Q10 in patients with Parkinson’s disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial

Overview of attention for article published in Neurological Research and Practice, August 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#16 of 186)
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 2 news outlets

twitter: 7 X users

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 41 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 14,983 followers.

RT @ScienceofPD: Also enjoyed Christine Klein's @UniLuebeck video exploring the new (and old) questions on genetics in #Parkinsons; Particu…

19 May 2021

Reply Repost Favourite

Also enjoyed Christine Klein's @UniLuebeck video exploring the new (and old) questions on genetics in #Parkinsons; Particular interest in their ongoing omics-based “mitochondrial risk burden” clinical trial testing coenzyme Q10 in #Parkinsons - protocol: h

19 May 2021

Reply Repost Favourite

RT @mr_spectroscopy: An omics-based strategy using coenzyme Q10 in patients with Parkinson's disease: concept evaluation in a double-blind…

17 Dec 2020

Reply Repost Favourite

An omics-based strategy using coenzyme Q10 in patients with Parkinson's disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial. https://t.co/n57GaQ7EOf https://t.co/C6lQM6bNdE

17 Dec 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.